PDCD1 and nasopharyngeal carcinoma: Here, we demonstrate that the chemotherapeutics cisplatin, 5-fluorouracil and gemcitabine, which are commonly used in the treatment of NPC patients, upregulate PD-1 on NK cells and PD-L1 on NPC cells and could therefore suppress NK-cell killing.